Silence Therapeutics (SLN) Asset Utilization Ratio (2025)
Historic Asset Utilization Ratio for Silence Therapeutics (SLN) over the last 5 years, with Q3 2025 value amounting to 0.17.
- Silence Therapeutics' Asset Utilization Ratio rose 52135.77% to 0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17, marking a year-over-year increase of 52135.77%. This contributed to the annual value of 0.27 for FY2024, which is 716.84% up from last year.
- Silence Therapeutics' Asset Utilization Ratio amounted to 0.17 in Q3 2025, which was up 52135.77% from 0.16 recorded in Q2 2025.
- Silence Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.17 during Q3 2025, with a 5-year trough of 46243.39 in Q4 2021.
- In the last 5 years, Silence Therapeutics' Asset Utilization Ratio had a median value of 0.06 in 2021 and averaged 8508.06.
- Its Asset Utilization Ratio has fluctuated over the past 5 years, first tumbled by 4734844359.45% in 2022, then surged by 52135.77% in 2025.
- Over the past 5 years, Silence Therapeutics' Asset Utilization Ratio (Quarter) stood at 46243.39 in 2021, then surged by 100.0% to 0.04 in 2022, then skyrocketed by 49.6% to 0.07 in 2023, then increased by 28.37% to 0.08 in 2024, then skyrocketed by 95.73% to 0.17 in 2025.
- Its last three reported values are 0.17 in Q3 2025, 0.16 for Q2 2025, and 0.14 during Q1 2025.